# FDA Inspection 1263112 - Shilpa Pharma Lifesciences Limited - March 07, 2025

Source: https://www.keypedia.com/records/fda_inspections/shilpa-pharma-lifesciences-limited/4dc7c44d-b5f7-4a6a-8575-8f994e1acdaf
Source feed: FDA_Inspections

> FDA Inspection 1263112 for Shilpa Pharma Lifesciences Limited on March 07, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1263112
- Company Name: Shilpa Pharma Lifesciences Limited
- Inspection Date: 2025-03-07
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1263112 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/shilpa-pharma-lifesciences-limited/dc767380-cc38-4510-ae07-2b40cdce4e9c)

Company: https://www.keypedia.com/companies/shilpa-pharma-lifesciences-limited/1267ea14-8591-45ec-9e82-4153a35a7028

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c